Literature DB >> 6284878

gamma-Aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice.

R W Horton, S A Prestwich, B S Meldrum.   

Abstract

The properties of gamma-aminobutyric acid recognition sites, benzodiazepine binding sites and the effect of exogeneous gamma-aminobutyric acid on benzodiazepine binding were determined in crude membrane fractions prepared from the brains of DBA/2 mice at ages before (8-9 and 17-18 days), during (22-23 and 28-29 days) and after (40-43 days) the age of high susceptibility to audiogenic seizures. These have been compared with data from age-matched mice of a strain (TO) with lower audiogenic seizure susceptibility. The number of high-affinity [3H]gamma-aminobutyric acid binding sites was lower at all ages in DBA/2 mice compared with TO mice, but the affinity was higher in DBA/2 mice. The number of low-affinity [3H]gamma-aminobutyric acid binding sites was lower at 8-9 days and 40-43 days in DBA/2 mice, but was not significantly different from TO mice at other ages. For [3H]flunitrazepam binding, the only difference found was a slight reduction in the number of binding sites at 28-29 days of age in DBA/2 mice. gamma-Aminobutyric acid stimulation of [3H]flunitrazepam binding was not significantly different up to 22-23 days of age, but was higher in DBA/2 mice at 28-29 days and lower at 40-43 days. Impairment of gamma-aminobutyric acid function is a possible permissive factor in the age-dependent audiogenic seizure susceptibility in DBA/2 mice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284878     DOI: 10.1111/j.1471-4159.1982.tb07972.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Proceedings of the British Pharmacological Society. University of Leicester, 6th-8th July, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

2.  Convulsant properties of GABA antagonists and anticonvulsant properties of ethanol in selectively bred long- and short-sleep mice.

Authors:  T J Phillips; D Kim; B C Dudek
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Genotype-dependent effects of GABAergic agents on sedative properties of ethanol.

Authors:  B C Dudek; T J Phillips
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  GABAergic mechanisms in the pathogenesis and treatment of epilepsy.

Authors:  B S Meldrum
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.

Authors:  A De Sarro; M Zappalá; A Chimirri; S Grasso; G B De Sarro
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

6.  Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine.

Authors:  N M Rupniak; S A Prestwich; R W Horton; P Jenner; C D Marsden
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  Social isolation does not alter brain regional benzodiazepine binding site numbers, affinity and coupling in the rat.

Authors:  A Morinan; V Parker; D A Rich; P Cariuk; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Benzodiazepine/gamma-aminobutyric acid receptor deficit in the midbrain of the seizure-susceptible gerbil.

Authors:  R W Olsen; J K Wamsley; R T McCabe; R J Lee; P Lomax
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Organic and Peptidyl Constituents of Snake Venoms: The Picture Is Vastly More Complex Than We Imagined.

Authors:  Alejandro Villar-Briones; Steven D Aird
Journal:  Toxins (Basel)       Date:  2018-09-26       Impact factor: 4.546

Review 10.  Structure, Function, and Modulation of γ-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic Prospective.

Authors:  Sadia Zafar; Ishrat Jabeen
Journal:  Front Chem       Date:  2018-09-11       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.